AdvaMed: AI medtech companies facing more risk with uncertainties at FDA - RAPS
Medtech companies developing artificial intelligence ( AI ) products are taking on more risk as the Trump administration's actions at the US Food ...
- Topics
- Healthcare
- Mentions
- Donald TrumpFDA
- Tracked via
- “AI Risks”